Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
Add to list
  1. Search results
  2. Towards the clinical evaluation of G...

Towards the clinical evaluation of Galsome-NEO, a glycolipid-adjuvanted mRNA cancer vaccine

Sofie Meulewaeter
(2024)
Author
Promoter
(UGent) and (UGent)
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Meulewaeter, Sofie. Towards the Clinical Evaluation of  Galsome-NEO, a Glycolipid-Adjuvanted  MRNA Cancer Vaccine. Ghent University. Faculty of Pharmaceutical Sciences, 2024.
APA
Meulewaeter, S. (2024). Towards the clinical evaluation of  Galsome-NEO, a glycolipid-adjuvanted  mRNA cancer vaccine. Ghent University. Faculty of Pharmaceutical Sciences, Ghent, Belgium.
Chicago author-date
Meulewaeter, Sofie. 2024. “Towards the Clinical Evaluation of  Galsome-NEO, a Glycolipid-Adjuvanted  MRNA Cancer Vaccine.” Ghent, Belgium: Ghent University. Faculty of Pharmaceutical Sciences.
Chicago author-date (all authors)
Meulewaeter, Sofie. 2024. “Towards the Clinical Evaluation of  Galsome-NEO, a Glycolipid-Adjuvanted  MRNA Cancer Vaccine.” Ghent, Belgium: Ghent University. Faculty of Pharmaceutical Sciences.
Vancouver
1.
Meulewaeter S. Towards the clinical evaluation of  Galsome-NEO, a glycolipid-adjuvanted  mRNA cancer vaccine. [Ghent, Belgium]: Ghent University. Faculty of Pharmaceutical Sciences; 2024.
IEEE
[1]
S. Meulewaeter, “Towards the clinical evaluation of  Galsome-NEO, a glycolipid-adjuvanted  mRNA cancer vaccine,” Ghent University. Faculty of Pharmaceutical Sciences, Ghent, Belgium, 2024.
@phdthesis{01J00RRS9ASC6RM9MSW0SYNR3W,
  author       = {{Meulewaeter, Sofie}},
  language     = {{eng}},
  pages        = {{VIII, 219}},
  publisher    = {{Ghent University. Faculty of Pharmaceutical Sciences}},
  school       = {{Ghent University}},
  title        = {{Towards the clinical evaluation of  Galsome-NEO, a glycolipid-adjuvanted  mRNA cancer vaccine}},
  year         = {{2024}},
}